Benjamin Hohl

Affiliations

  • Chief Financial Officer at Enliven Therapeutics Inc. (ELVN), 2025-06-17
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ELVN $22.55 3,000 $67,655.40 23,000 2025-06-13 Filing
ELVN $16.18 3,250 $52,593.45 23,000 2025-05-27 Filing
ELVN $19.12 69 $1,319.02 23,000 2025-04-28 Filing
ELVN $18.68 3,181 $59,418.54 23,069 2025-04-28 Filing
ELVN $21.33 3,250 $69,320.88 23,000 2025-03-27 Filing